SYNTHESIS AND BIOLOGICAL-ACTIVITY OF THIAZOLYLINDOLEQUINONES, ANALOGS OF THE NATURAL PRODUCT BE-10988

被引:26
作者
MOODY, CJ
SWANN, E
HOULBROOK, S
STEPHENS, MA
STRATFORD, IJ
机构
[1] CHURCHILL HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,OXFORD OX3 7LJ,ENGLAND
[2] MRC,RADIOBIOL UNIT,DIDCOT OX11 0RD,OXON,ENGLAND
基金
英国医学研究理事会;
关键词
D O I
10.1021/jm00006a024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of analogues of the naturally occurring thiazolylindolequinone BE 10988, a reported potent inhibitor of topoisomerase II, have been prepared and evaluated. The compounds were synthesized from 4-(benzyloxy)-S-methoxy-1-methylindole by appropriate substitution at the indole 3-position followed by standard thiazole ring-forming reactions. The toxicity of these potentially bioreductively activated indolequinones was measured in Chinese hamster V79 cells under aerobic and hypoxic conditions. In addition, toxicity was measured in a human breast cancer cell line that shows amplification of the topo II alpha gene and hypersensitivity to known topo II inhibitors such as mAMSA and mitoxantrone. Using a DNA decatenation assay, a comparison was also made of the inhibitory effects of BE 10988 and mitoxantrone on topo II activity.
引用
收藏
页码:1039 / 1043
页数:5
相关论文
共 23 条
[11]   DIFFERENTIAL MODULATION OF DOXORUBICIN TOXICITY TO MULTIDRUG AND INTRINSICALLY DRUG-RESISTANT CELL-LINES BY ANTIESTROGENS AND THEIR MAJOR METABOLITES [J].
KIRK, J ;
HOULBROOK, S ;
STUART, NSA ;
STRATFORD, IJ ;
HARRIS, AL ;
CARMICHAEL, J .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1189-1195
[12]   SYNTHESIS OF THE TOPOISOMERASE-II INHIBITOR BE-10988 [J].
MOODY, CJ ;
SWANN, E .
TETRAHEDRON LETTERS, 1993, 34 (12) :1987-1988
[13]   SYNTHESIS OF THE NATURALLY-OCCURRING INDOLEQUINONE BE-10988, AN INHIBITOR OF TOPOISOMERASE-2 [J].
MOODY, CJ ;
SWANN, E .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1993, (21) :2561-2565
[14]   CYCLOPROPAMITOSENES - NOVEL BIOREDUCTIVE ANTICANCER AGENTS - MECHANISM OF ACTION AND ENZYMATIC REDUCTION [J].
MOODY, CJ ;
OSULLIVAN, N ;
STRATFORD, IJ ;
STEPHENS, MA ;
WORKMAN, P ;
BAILEY, SM ;
LEWIS, A .
ANTI-CANCER DRUGS, 1994, 5 (03) :367-372
[15]   A NEW TOPOISOMERASE-II INHIBITOR, BE-10988, PRODUCED BY A STREPTOMYCETE .1. TAXONOMY, FERMENTATION, ISOLATION AND CHARACTERIZATION [J].
OKA, H ;
YOSHINARI, T ;
MURAI, T ;
KAWAMURA, K ;
SATOH, F ;
FUNAISHI, K ;
OKURA, A ;
SUDA, H ;
OKANISHI, M ;
SHIZURI, Y .
JOURNAL OF ANTIBIOTICS, 1991, 44 (05) :486-491
[16]   NOVEL CYTOTOXIC TOPOISOMERASE-II INHIBITING PYRROLOIMINOQUINONES FROM FIJIAN SPONGES OF THE GENUS ZYZZYA [J].
RADISKY, DC ;
RADISKY, ES ;
BARROWS, LR ;
COPP, BR ;
KRAMER, RA ;
IRELAND, CM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (05) :1632-1638
[17]  
ROBSON CN, 1987, CANCER RES, V47, P1560
[18]   DNA TOPOISOMERASES AS TARGETS FOR CANCER-THERAPY [J].
ROSS, WE .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (24) :4191-4195
[19]  
SMITH K, 1993, ONCOGENE, V8, P933
[20]   THE DIFFERENTIAL HYPOXIC CYTO-TOXICITY OF BIOREDUCTIVE AGENTS DETERMINED INVITRO BY THE MTT ASSAY [J].
STRATFORD, IJ ;
STEPHENS, MA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (04) :973-976